Jung-ah Lee

Cheongju-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Immunogenicity and Cross-Protection Efficacy of a Genotype F-Derived Attenuated Virus Vaccine Candidate against Mumps Virus in Mice.

Immunogenicity and Cross-Protection Efficacy of a Genotype F-Derived Attenuated Virus Vaccine Candidate against Mumps Virus in Mice.

Journal: Vaccines
Published: May 10, 2024

Corrigendum to "Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants" [Vaccine 41(11) (2023) 1892-1901].

Corrigendum to "Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants" [Vaccine 41(11) (2023) 1892-1901].

Journal: Vaccine
Published: October 20, 2023

Boosting with variant-matched adenovirus-based vaccines promotes neutralizing antibody responses against SARS-CoV-2 Omicron sublineages in mice.

Boosting with variant-matched adenovirus-based vaccines promotes neutralizing antibody responses against SARS-CoV-2 Omicron sublineages in mice.

Journal: International journal of antimicrobial agents
Published: August 02, 2023

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants.

Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants.

Journal: PloS one
Published: July 19, 2023

Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants.

Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants.

Journal: Vaccine
Published: June 23, 2022

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.

Journal: Virology
Published: March 24, 2022

Optimization of Zika DNA vaccine by delivery systems.

Optimization of Zika DNA vaccine by delivery systems.

Journal: Virology
Published: September 29, 2020

The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.

The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.

Journal: Vaccine
Published: December 09, 2017

Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.

Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.

Journal: PloS one
Published: September 22, 2017

In vitro and in vivo studies of deglycosylated chimeric porcine reproductive and respiratory syndrome virus as a vaccine candidate and its realistic revenue impact at commercial pig production level.

In vitro and in vivo studies of deglycosylated chimeric porcine reproductive and respiratory syndrome virus as a vaccine candidate and its realistic revenue impact at commercial pig production level.

Journal: Vaccine
Published: April 26, 2017

An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.

An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice.

Journal: PloS one
Published: February 07, 2017

Sequence analysis of the first C2 subgenogroup strain of enterovirus 71 isolated in Korea.

Sequence analysis of the first C2 subgenogroup strain of enterovirus 71 isolated in Korea.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: August 04, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026